Hyperkalaemia in Heart Failure

Hyperkalaemia has become an increasingly prevalent finding in patients with heart failure (HF), especially with renin–angiotensin–aldosterone system (RAAS) inhibitors and angiotensin–neprilysin inhibitors being the cornerstone of medical therapy. Patients living with HF often have other comorbiditie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Umar, Sidhu, Kiran, Zieroth, Shelley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Comorbidities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150383/
https://www.ncbi.nlm.nih.gov/pubmed/34094588
http://dx.doi.org/10.15420/cfr.2020.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150383/
https://www.ncbi.nlm.nih.gov/pubmed/34094588
http://dx.doi.org/10.15420/cfr.2020.29

Ejemplares similares